MedPath

SANOFI-AVENTIS GROUPE

🇦🇪United Arab Emirates
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

148

Active:148
Completed:0

Trial Phases

1 Phases

Phase 1:110

Drug Approvals

15

CIMA_AEMPS:9
NMPA:4
EMA:2

Drug Approvals

Dupilumab Injection

Product Name
达必妥
Approval Number
国药准字SJ20235003
Approval Date
Sep 26, 2023
NMPA

Irbesartan and Hydrochlorothiazide Tablets

Product Name
安博诺
Approval Number
国药准字J20130041
Approval Date
Jul 9, 2020
NMPA

Clopidogrel Bisulfate Tablets

Product Name
波立维
Approval Number
国药准字J20180029
Approval Date
Jul 7, 2020
NMPA

Rasburicase for injection

Product Name
法舒克
Approval Number
国药准字J20180087
Approval Date
Dec 3, 2018
NMPA

Clinical Trials

Distribution across different clinical trial phases (110 trials with phase data)• Click on a phase to view related trials

Phase 1
110 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.